Abpro stock

Abpro Stock

HealthTech

Looking to sell Abpro stock or options?

Founded: 2004Funding to Date: $70Mhttps://www.abpro.com

Abpro is a biotechnology firm focused on treating and curing diseases in patients. Utilizing synthetic biology and immunology, the company produces medications against new and challenging targets. This allows biotech and pharmaceutical companies to generate a plethora of therapeutic antibodies against targets typically hard to tackle.

Collective explained in 2 minutes

Learn how Collective's solutions enable you to manage your risk and maximize your wealth

Learn more